文献速递白血病

金诺芬联合维生素C靶向急性髓系白血病细胞的氧化还原脆弱性

Targeting the redox vulnerability of acute myeloid leukaemia cells with a combination of auranofin and vitamin C.
PubMed 文献 · Br J Haematol · 2024-08-01

本研究探讨金诺芬(AUF)联合维生素C(VC)对急性髓系白血病(AML)细胞的杀伤作用。在多种髓系亚型白血病细胞系中,该组合协同高效杀伤细胞,伴随活性氧升高、ATP耗竭、4E-BP1和p70S6K快速去磷酸化及蛋白合成强抑制。在22例原代AML标本中,药理浓度AUF/VC可清除多数样本的白血病CD34+细胞,对正常脐血CD34+细胞毒性较低。

要点

  • AUF/VC组合在多种AML细胞系中协同高效杀伤细胞。
  • 早期事件包括活性氧升高、ATP耗竭、4E-BP1和p70S6K去磷酸化及蛋白合成抑制。
  • 药理浓度AUF/VC可清除多数原代AML标本的白血病CD34+细胞,对正常脐血CD34+细胞毒性较低。

核心结论

  • 靶向AML细胞的氧化还原脆弱性,AUF/VC组合可能是一种潜在的抗AML治疗策略。

研究设计与样本

  • 研究使用来源于不同髓系亚型的白血病细胞系,并纳入22例不同AML亚型的原代AML标本进行体外药物组合实验。

主要发现

  • AUF/VC组合协同且高效杀伤不同髓系亚型白血病细胞系。
  • AUF/VC处理早期即可诱导活性氧升高和ATP耗竭。
  • AUF/VC处理早期出现4E-BP1和p70S6K快速去磷酸化,并强烈抑制蛋白合成。
  • 在22例原代AML标本中,药理浓度AUF/VC可清除多数样本的白血病CD34+细胞。
  • 药理浓度AUF/VC对正常脐血CD34+细胞的毒性低于对原代白血病CD34+细胞的毒性。

关键数值与推荐

  • 原代AML标本共22例,来源于不同AML亚型。
  • AUF/VC在药理可达到的浓度下有效清除多数原代AML样本的白血病CD34+细胞。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute myeloid leukaemia (AML) is a heterogeneous disease characterized by complex molecular and cytogenetic abnormalities. Pro-oxidant cellular redox status is a common hallmark of AML cells, providing a rationale for redox-based anticancer strategy. We previously discovered that auranofin (AUF), initially used for the treatment of rheumatoid arthritis and repositioned for its anticancer activity, can synergize with a pharmacological concentration of vitamin C (VC) against breast cancer cell line models. In this study, we observed that this drug combination synergistically and efficiently killed cells of leukaemic cell lines established from different myeloid subtypes. In addition to an induced elevation of reactive oxygen species and ATP depletion, a rapid dephosphorylation of 4E-BP1 and p70S6K, together with a strong inhibition of protein synthesis were early events in response to AUF/VC treatment, suggesting their implication in AUF/VC-induced cytotoxicity. Importantly, a study on 22 primary AML specimens from various AML subtypes showed that AUF/VC combinations at pharmacologically achievable concentrations were effective to eradicate primary leukaemic CD34+ cells from the majority of these samples, while being less toxic to normal cord blood CD34+ cells. Our findings indicate that targeting the redox vulnerability of AML with AUF/VC combinations could present a potential anti-AML therapeutic approach.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Hei Z, Yang S, Ouyang G, et al. Targeting the redox vulnerability of acute myeloid leukaemia cells with a combination of auranofin and vitamin C. Br J Haematol. 2024. PMID: 39087522. doi:10.1111/bjh.19680

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。